Thimble Point Acquisition Corp Cl A (THMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | THMA | CASI | SCYX | ||
| Company | Thimble Point Acquisition Corp Cl A | Casi Pharmaceuticals Inc | Scynexis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.15 | 5.25 | 1.9400 | ||
| High | 9.33 | 5.74 | 1.9600 | ||
| Low | 9.15 | 5.25 | 1.8000 | ||
| Last | 9.30 | 5.73 | 1.8700 | ||
| Change | +0.18 | +0.48 | -0.0700 | ||
| % Change | +1.93% | +9.14% | -3.61% | ||
| Volume | 700 | 97,200 | 153,300 | ||
| 20-Day Average Volume | 281,600 | 677,045 | 141,235 | ||
| Previous Close | 9.12 | 5.25 | 1.9400 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.83 | 3.95 | 2.0198 | ||
| 20-Day Raw Stochastic | 26.62% | 99.68% | 19.35% | ||
| 20-Day Relative Strength | 23.36% | 70.05% | 44.07% | ||
| Weighted Alpha | -9.39 | +38.56 | -36.24 | ||
| Today's Opinion | N/A | 24% Buy | 8% Buy | ||
| Previous Opinion | N/A | 24% Buy | 24% Buy | ||
| Last Month's Opinion | N/A | 24% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.34% since 11/26/21 | +16.94% since 06/27/24 | -7.88% since 06/27/24 | ||
| Low | 9.01 on 12/02/21 | 4.57 on 06/28/24 | 1.8000 on 07/05/24 | ||
| High | 10.10 on 11/29/21 | 5.74 on 07/05/24 | 2.0700 on 06/28/24 | ||
| 1-Month | |||||
| %Chg | -6.72% since 11/03/21 | +63.25% since 06/05/24 | -19.74% since 06/05/24 | ||
| Low | 9.01 on 12/02/21 | 2.61 on 06/18/24 | 1.7500 on 06/21/24 | ||
| High | 10.10 on 11/29/21 | 5.74 on 07/05/24 | 2.3700 on 06/06/24 | ||
| 3-Month | |||||
| %Chg | -6.06% since 09/03/21 | +79.06% since 04/05/24 | +9.36% since 04/05/24 | ||
| Low | 9.01 on 12/02/21 | 2.05 on 04/17/24 | 1.3700 on 04/17/24 | ||
| High | 10.10 on 11/29/21 | 5.74 on 07/05/24 | 3.0700 on 05/20/24 | ||
| 6-Month | |||||
| %Chg | -4.12% since 06/03/21 | -13.96% since 01/05/24 | -1.06% since 01/05/24 | ||
| Low | 9.01 on 12/02/21 | 2.05 on 04/17/24 | 1.3500 on 03/19/24 | ||
| High | 10.10 on 11/29/21 | 8.19 on 01/26/24 | 3.0700 on 05/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 76,361 | 76,788 | 70,649 | ||
| Shares Outstanding, K | 8,211 | 13,401 | 37,780 | ||
| Annual Sales | 0 | 33,880,000 | 140,140,000 | ||
| Annual Net Income | 0 | -26,940,000 | 67,040,000 | ||
| Last Quarter Sales | 0 | 3,410,000 | 1,370,000 | ||
| Last Quarter Net Income | 5,830,000 | -9,530,000 | 410,000 | ||
| 60-Month Beta | N/A | 0.68 | 1.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.71 on 05/14/24 | -0.15 on 05/08/24 | ||
| Latest Earnings Date | N/A | 08/09/24 | 08/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 1.03 | ||